(Q43078861)

English

Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities

scientific article published on 30 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

anticoagulation

1 reference

based on heuristic

inferred from title

Kawasaki disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Brian W McCrindle

9

object named as

Brian W McCrindle

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

author name string

Cedric Manlhiot

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Leonardo R Brandão

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Zeeshanefatema Somji

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Amy L Chesney

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Catherine MacDonald

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Rebecca C Gurofsky

6

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Tarun Sabharwal

7

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Nita Chahal

8

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Pediatric Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

834-842

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

https://scigraph.springernature.com/pub.10.1007/s00246-010-9715-8

0 references

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1007%2FS00246-010-9715-8

21 January 2018

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00246-010-9715-8

21 January 2018

Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1007%2FS00246-010-9715-8

21 January 2018

Regression of coronary aneurysms in patients with Kawasaki syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00246-010-9715-8

21 January 2018

Endothelial dysfunction in adult patients with a history of Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fate of coronary arterial aneurysms in Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombotic therapy in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary diameter in normal infants, children and patients with Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic determinants of response to warfarin during initial anticoagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coagulopathy and platelet activation in Kawasaki syndrome: Identification of patients at high risk for development of coronary artery aneurysms

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HEPARIN IN THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCHOPULMONARY DISEASE

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary artery dimensions may be misclassified as normal in Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of low molecular weight heparin in pediatric patients: a prospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The apoptotic endonuclease DFF40/CAD is inhibited by RNA, heparin and other polyanions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological therapy for patients with Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality among persons with a history of Kawasaki disease in Japan: can paediatricians safely discontinue follow-up of children with a history of the disease but without cardiac sequelae?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality among persons with a history of Kawasaki disease in Japan: existence of cardiac sequelae elevated the mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced bone density in children on long-term warfarin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral anticoagulation therapy in pediatric patients: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral anticoagulation therapy in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/20431996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00246-010-9715-8

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43078861&oldid=1980137546"